Literature DB >> 28665868

AGE-RELATED MACULAR DEGENERATION AND THE RISK OF ALL-CAUSE AND CARDIOVASCULAR MORTALITY: A Meta-Analysis of Cohort Studies.

Xueling Xin1, Yongye Sun2, Shiru Li1, Hui Xu1, Dongfeng Zhang1.   

Abstract

PURPOSE: We evaluated the association between age-related macular degeneration (AMD) and the risk of all-cause and cardiovascular mortality by meta-analyses of data from prospective studies.
METHODS: A literature search was performed in PubMed, Web of Science, Embase, Cocharne Library, and China National Knowledge Infrastructure for relevant articles published up to December 2016. We estimated hazard ratios with 95% confidence intervals with fixed-effect models and conducted meta-regression to explore the potential sources of heterogeneity. Small-study effect was estimated by Egger's test and funnel plot.
RESULTS: We identified 13 population-based prospective cohort studies that examined the relationship between AMD and all-cause and cardiovascular mortality. Overall, the hazard ratios (95% confidence intervals) of all-cause mortality and cardiovascular mortality associated with any AMD were 1.15 (1.05-1.27) and 1.05 (95% confidence intervals: 0.87-1.26), respectively. The risk of all-cause mortality and cardiovascular mortality associated with early AMD were 1.08 (1.00-1.18) and 1.05 (0.89-1.24), and the associations with late AMD were 1.23 (1.11-1.36) and 1.28 (1.04-1.57), respectively. No evidence of small-study effect was found.
CONCLUSION: This meta-analysis indicated that AMD, especially late AMD, was associated with increased risk of all-cause mortality and cardiovascular mortality based on comparisons with people who did not have AMD and who were of similar age and sex.

Entities:  

Mesh:

Year:  2018        PMID: 28665868     DOI: 10.1097/IAE.0000000000001741

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?

Authors:  Fabrizio Scotti; Paolo Milani; Marco Setaccioli; Silvia Maestroni; Nicolai Sidenius; Valentina De Lorenzi; Amedeo Massacesi; Fulvio Bergamini; Gianpaolo Zerbini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-07       Impact factor: 3.117

2.  The flicker response of venous oxygen saturation is significantly reduced in the early and late stages of age-related macular degeneration.

Authors:  Emilia Donicova; L Ramm; R Augsten; M Hammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-28       Impact factor: 3.117

3.  Geographic atrophy severity and mortality in age-related macular degeneration.

Authors:  Aneesha Ahluwalia; Liangbo L Shen; Evan M Chen; Mengyuan Sun; Michael M Park; Benjamin K Young; Lucian V Del Priore
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-19       Impact factor: 3.535

4.  Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008.

Authors:  Zhuoting Zhu; Wei Wang; Stuart Keel; Jian Zhang; Mingguang He
Journal:  JAMA Ophthalmol       Date:  2019-03-01       Impact factor: 7.389

5.  Risk factors for cardiovascular disease from a population-based screening study in Tianjin, China: a cohort study of 36,215 residents.

Authors:  Yingyi Zhang; Hongliang Cong; Chen Man; Yu Su; Hongxia Sun; Hua Yang; Zhigang Guo
Journal:  Ann Transl Med       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.